The Build Back Better Act's drug inflation rebate provision would reduce premiums by $3 billion (0.4%) in 2023 and $21 billion (1.7%) in 2031. (Photo: Shutterstock)
A new analysis estimates that introducing inflation rebates on most prescription drugs — a provision of the Build Back Better Act, which was passed in November by the U.S. House of Representatives — would lower employers' health insurance premiums by $111 billion over the next decade.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
